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Abstract
Background: Polychlorinated biphenyls (PCBs) are a family of structurally related chlorinated aromatic hydrocarbons.
Numerous studies have documented a wide spectrum of biological effects of PCBs on human health, such as
immunotoxicity, neurotoxocity, estrogenic or antiestrogenic activity, and carcinogensis. The role of PCBs as etiologic agents
for breast cancer has been intensively explored in a variety of in vivo, animal and epidemiologic studies. A number of
investigations indicated that higher levels of PCBs in mammary tissues or sera correlated to breast cancer risk, and PCBs
might be implicated in advancing breast cancer progression.
Methodology/Principal Findings: In the current study, we for the first time report that PCBs greatly promote the ROCK
activity and therefore increase cell motility for both non-metastatic and metastatic human breast cancer cells in vitro. In the
in vivo study, PCBs significantly advance disease progression, leading to enhanced capability of metastatic breast cancer
cells to metastasize to bone, lung and liver. Additionally, PCBs robustly induce the production of intracellular reactive
oxygen species (ROS) in breast cancer cells; ROS mechanistically elevate ROCK activity.
Conclusions/Significance: PCBs enhance the metastatic propensity of breast cancer cells by activating the ROCK signaling,
which is dependent on ROS induced by PCBs. Inhibition of ROCK may stand for a unique way to restrain metastases in
breast cancer upon PCB exposure.
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Introduction
Polychlorinated biphenyls (PCBs) are chlorinated aromatic
hydrocarbons with 209 congeners. They are highly stable and
lipophilic chemicals widely distributed in the environment.
Although the production and massive use of PCBs have been
banned in the 1970 s, they persist in the environment,
biomagnify through food chains and consequently accumulate
in fat tissues in humans [1,2,3]. For many years, PCBs are
concerned as etiologic agents for breast cancer and other cancers.
Initial studies indicated higher levels of PCBs in mammary tissues
or sera corresponded to increased risk of breast cancer [4,5];
however, later studies showed no positive association between
PCB exposure and breast cancer development, with possible
positive correlations to some specific PCB congeners or among
particular populations [6,7,8]. Some recent investigations sug-
gested that PCBs were implicated in promoting breast cancer
progression, and some particular PCB congeners might contrib-
ute to high-grade tumors and overall poor prognosis in breast
cancer patients [9,10,11].
Breast cancer is the most commonly diagnosed cancer and the
second leading cause of cancer-related deaths among women.
The real threat to lives of breast cancer patients is not the
primary tumor in the breast, but secondary tumors in other
organs (e.g. bone and lung) which accounts for 90% of deaths of
breast cancer patients. Once breast cancer cells metastasize and
form tumors in distant organs, the disease is incurable with
available therapeutics [12]. Until now, the underlying mecha-
nisms responsible for breast cancer metastasis remain to be
elucidated, and there is by far no metastasis-specific therapy in
clinical practice.
The Rho-associated kinases, ROCK 1 and 2 (here referred to as
ROCK), are major mediators of Rho activity [13]. ROCK is
implicated in the regulation of in vitro invasion and motility and in
vivo metastasis of cancers [14]. Clinical studies show that the
expression of ROCK is significantly increased in human breast
cancer tumors with metastases than those without metastases
[15,16]. And increased expression of ROCK is associated with
higher pathological grades and later stages, and its expression level
is strongly correlated to the overall survival in breast cancer
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e11272patients [15]. Overexpression of ROCK can significantly enhance
in vitro cell invasion/migration in cancer cells [17,18,19]; however,
the expression of the dominant-negative ROCK and the ROCK
inhibitor, Y27632, can massively suppress in vitro cancer cell
invasion/migration and in vivo motility and dissemination
[18,20,21,22].
In this study, to delineate the associations between the PCB
exposure and breast cancer risk and progression, we assess the
effects of PCBs on the tumorigenic and metastatic features of
breast cancer cells. Overall, we describe a novel role of PCBs in
enhancing metastatic properties of breast cancer cells by activating
the ROCK signaling.
Results and Discussion
The concerns with respect to likely carcinogenic influence on
mammary tissues with exposure to PCBs derived from the
estrogenic activity of these compounds, which have the ability to
mimic or interfere with the action of endogenous hormones
[23,24,25]. Because of their lipophilic nature, PCBs tend to
accumulate in adipose tissues, and therefore could be detectable in
human mammary tissues and even in milk. Epidemiological
studies suggested a number of congeners are simultaneously
detected in serum, breast milk and adipose tissue in humans
[6,8,26,27]. Due to their estrogenic activity, PCBs have been
documented to disrupt the endocrine systems of animals and
humans [28,29], and the combination of different PCBs could
behave synergistically in presenting their estrogenic potency [30].
To mimic co-exposure to PCB congeners, in this study we used the
commercially available PCB mix (equal amount of No. 28, 52,
101, 138, 153, 180 and 209) of frequently detected PCBs in human
subjects. We employed estrogen receptor-positive (ER
+) MCF-7
cells and estrogen receptor-negative (ER
-) MDA-MB-231 cells in
order to discriminate the ER-dependent and -independent effects.
There was a rather mild effect of the PCB mix on cell growth and
survival at low concentrations (,60 nM) for both ER
+ MCF-7 and
Figure 1. The cytotoxicity induced by PCBs on MDA-MB-231 cells. (A) Phase-contrast images of cell morphology from MDA-MB-231 cells
treated with/without the PCB mix at 60 nM for 24 hrs. Original maginification, 6200. (B) FACS analysis of apoptosis induced by PCBs at 60 nM for
24 hrs in MDA-MB-231 cells using FITC-Annexin V and PI stains. Early apoptotic cells (lower right), necrotic cells (upper left) and late apoptotic/
necrotic cells (upper right) are shown as arrows indicate.
doi:10.1371/journal.pone.0011272.g001
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- MDA-MB-231 cells (data not shown); however, PCBs exerted
significant cytotoxicity on these cells and induce cell death at high
concentrations (.60 nM). As shown in Fig. 1A, distinct apoptotic
morphology was observed in MDA-MB-231 cells treated with
60 nM PCBs for 24 hrs compared to the vehicle control, as the
PCB-treated cells became round and tended to detach from the
plate. The apoptosis induced by PCBs was confirmed by an
analysis of flow cytometry using FITC-Annexin V and propidium
iodide (PI) stains. PCBs dramatically induced cell death as
indicated by increased early apoptotic cells (37.05% VS 2.93%),
necrotic cells (13.70% VS 3.04%) and late apoptotic/necrotic cells
(8.04% VS 1.31%) (P,0.001, n=3), compared to the control
(Fig. 1B).
The previous studies indicated that PCBs were correlated with
more aggressive breast cancers, and might promote tumor
progression [9,10,11]. Thus, the cell motility influenced by the
PCB mix was assessed in a transwell migration assay as previously
described [16]. Compared to the non-metastatic cells, MCF-7,
metastatic cells, MDA-MB-231, displayed robust migration
ability, as the number of transmigrated cells was 8 times greater
than that of MCF-7 cells (P,0.001, n=6) (Fig. 2A&B). Upon the
stimulation of PCBs at 30 nM for 24 hrs, the cell motility was
tremendously increased (,10 times) for both ER
+ MCF-7 and
ER
- MDA-MN-231 (Fig. 2A&B, P,0.001), suggesting the
presence of ER is not an indispensable for PCB-facilitated cell
migration. At higher concentrations of PCBs (e.g. 60 nM), the cell
motility was greatly reduced (Fig. 2A&B, P,0.001) presumably
due to their cytotoxicity as discussed above (Fig. 1). In addition,
all PCB congeners (namely 28, 52, 101, 138, 153, 180 and 209)
used in this study are not structurally similar to 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) which has the ability to
bind to and activate the ligand-activated transcription factor, the
aryl hydrocarbon receptor (AhR). These non-dioxin-like PCBs
therefore have no ability to bind to the AhR and activate its
downstream signaling [31]. Thus, the PCB-promoted effect on
cell motility is independent of the ER signaling and the AhR
signaling as well.
To gain insight into the role of PCBs in regulating cell
migration/invasion, we looked into the changes of metastatic
capability of MDA-MB-231 cells upon exposure of PCBs in vivo
using a mouse model of breast cancer metastasis (Fig. 3A). As
shown in Fig. 3B, the growth of primary tumors was little affected
after 4 weeks of PCB exposure, consistent with the in vitro
observation on cell proliferation (data not shown). However, PCBs
greatly enhanced the capability of MDA-MB-231 cells to
metastasize to lung, liver and bone. 2 out of 4 mice developed
lung metastasis, and 1 out of 4 mice developed liver metastasis
among the PCB-treated mice. In contrast, no mice in the vehicle
control group developed either lung or liver metastasis
(Fig. 4A&C). Although 50% of mice for both groups developed
bone metastasis in bilateral hind limbs, the mass of metastatic
tumors in the PCB-treated mice was significantly greater than that
in the control mice (Fig. 4B&C, n=4, P,0.05). This observation is
consistent with a previous epidemiological finding that high
concentrations of PCBs in mammary adipose tissues were
associated with high-grade tumors and overall poor prognosis in
breast cancer patients [11].
To shed light on the mechanism by which PCBs promote in
vitro cell motility and in vivo metastasis of breast cancer cells, we
investigated the potential downstream targets of PCBs. Illumi-
Figure 2. PCBs enhance cell migration in breast cancer cells. Cell motility was examined from a transwell migration assay in MCF-7 and MDA-
MB-231 cells treated with the PCB mix at 30 or 60 nM for 24 hrs. After the DAPI staining (blue), two images were randomly taken from three
individual replicates under a microscope, and transmigrated cells in the chamber filters in each image were counted. Representative images for MCF-
7 (A) and MDA-MB-231 (B) cells are shown, and the numbers of transmigrated cells were quantified (n=6). *, P,0.001, compared with the vehicle
control and the 60 nM group.
doi:10.1371/journal.pone.0011272.g002
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PCBs on the ROCK activity. PCBs significantly activated
ROCK activity by 30% or so, and this effect could be
attenuated by a specific ROCK inhibitor, Y27632(Fig. 5A,
n=3, P,0.05). Corresponding to the changes of ROCK
activity, the substrate of ROCK, myosin light chain (MLC),
was more phosphorylated upon the treatment of PCBs than the
vehicle control; the increase of phosphorylated MLC (P-MLC)
was weakened by Y27632 (Fig. 5A). PCBs largely induced the
production of intracellular reactive oxygen species (ROS) in
breast cancer cells by 40% (Fig. 5B), along with the increase of
ROCK activity and the level of phosphorylated MLC (Fig. 5C).
Importantly, we demonstrated that the increase of ROS
mechanistically led to elevated ROCK activity induced by
PCBs, as the increase for both the ROCK activity and the level
of phosphorylated MLC could be undermined by the pre-
treatment of beta-mercaptoethanol (b-ME) (Fig. 5C, n=3,
P,0.05).
Although the ability of PCBs in provoking tumor initiation
and development has been observed, the mechanism remains to
be elucidated. Numerous possible mechanisms have been
explored, such as the estrogenic activity, effects on vitamin A
metabolism and intercellular communication, and induction of
oxidative stress (ROS) [32,33].The potential interaction be-
tween ROCK- and ROS-signal transduction pathways has been
suggested in previous studies [34,35,36]: ROCK is activated by
arsenic trioxide (As2O3) ,as t r o n gR O S - i n d u c e r[ 3 5 ] .F u r t h e r ,
hypoxia-induced ROS activates the RhoA/ROCK pathway
[36].
PCBs are widespread and persistent environmental pollutants
that impose potential hazards on human health. The possible
correlation between environmental PCB exposure and breast
cancer risk exists biologically plausible, and mounting evidence
indicates that PCB exposure contributes to the aggressiveness and
metastases of breast cancer. The findings from the current study
suggest that PCBs potently augment the ROCK signaling to
Figure 3. Role of PCBs in breast cancer progression and metastasis in the mouse model. (A) A schematic of the mouse model used in this
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PCBs is dependent on ROS, but independent of the ER signaling
and the AhR signaling (Fig. 6). Inhibition of ROCK, therefore,
appears to represent a novel therapeutic approach for metastases
in breast cancer upon PCB exposure.
Materials and Methods
Chemicals
The PCB congener mix (equal amount of No. 28, 52, 101, 138,
153, 180 and 209) was purchased from Sigma. Stock solutions of
these compounds were diluted in 100% ethanol and added to the
culture medium immediately before use. Equal volume of PBS
corresponding to different concentrations of the PCB mix was
diluted in 100% ethanol as the vehicle control.
Human Breast cancer cell lines and cell culture
Human Breast cancer cell lines, MCF-7 and MDA-MB-231
were stored and cultured as described previously [16,37,38].
Animal experiments
All mouse care and experimentation were approved by the
Committee of Animal Care at the RCEES, Chinese Academy of
Sciences. Immunodeficient (NOD/SCID) mice were maintained
under aseptic sterile conditions. Surgeries were performed under
sterile conditions and mice received antibiotics (trimethoprim
sulfa) in the drinking water for 2 weeks following all surgical
procedures. Experimental set-up was similar to the methods
described in our previous publication [16]. Briefly, bilateral fourth
mammary fat pads (MFPs) were injected with 1 million MDA-MB-
231 breast cancer cells after a midline incision was made and the
Figure 4. PCBs enhance MDA-MB-231 breast cancer cell metastases in vivo. (A) The occurrence of metastases in all organs tested in the PCB-
treated mice and vehicle control mice. Metastases were examined using the Xenogen 2000 and the IVIS software as previously described [16]. (B) The
quantified data of metastatic tumors (reflected by photon flux, photons/sec [16]) in mouse skeleton (n=4). (C) Representative images of metastases
in mouse liver, lung and skeleton from the bioluminescent imaging.
doi:10.1371/journal.pone.0011272.g004
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injected in 1:3 diluted 20 ml matrigel (BD Biosciences):sterile PBS
using a Hamilton syringe (Hamilton Co.). 10 wks later when the
tumor size reached about 200 mm
3, the mouse was sacrificed. The
primary tumors were removed and cut into small pieces in a cube
shape with a scissor. 0.02 g of tumor tissues were implanted
underneath MFPs of 8 wk old mice. 2 weeks later when primary
tumors reached ,75 mm
3, one group of mice received one dose of
intraperitoneal (i.p.) injection of the PCB mix diluted in ethanol
(3 nM/kg, in 100 ml).Control mice received ethanol-diluted PBS.
Bioluminescent imaging was performed 4 wks post the
injection, with both primary tumors and metastases examined
using the Xenogen 2000 and the IVIS software. Mice were
administrated i.p. injections of luciferin (100 nl of 1 mg/mL;
Molecular Probes), and after 10 minutes, anesthetized (isoflurane
inhalation) for imaging of primary tumors. Following euthaniza-
tion using CO2, mouse hind limbs, lungs, livers, kidneys and
other tissues were removed for separate imaging, and detection of
metastases.
Western blot analysis
Protein extracts were prepared from cells, and 20 mg of each
was used for separation by 4–12% SDS-PAGE and processed for
Western blot analyses as described previously [39]. Antibodies
used were the anti-GAPDH (1:1,000, Santa Cruz Biotechnology),
and anti–phosphorylated MLC (1:1,000, Sigma).
Figure 5. The signaling stimulated by PCBs in MDA-MB-231 cells. (A) The relative ROCK activity and Western blot analysis of P-MLC in MDA-
MB-231 cells treated with the PCB mix (30 nM) with or without the ROCK inhibitor, Y27632 (10 mM) for 24 hrs (n=3). (B) ROS production in MDA-MB-
231 cells upon PCB treatment. DCF fluorescence in cells were measured by FACS analysis after 6-hr PCB treatment with or without b-ME (14.3 mM)
(n=3). (C) The relative ROCK activity and Western blot analysis of P-MLC in cells upon PCB treatment for 6 hrs with or without b-ME (n=3). *, P,0.05,
compared with the vehicle control and the PCBs+b-ME group. The intensities of autoradiogram in Western blots were quantified with Image J
(rsbweb.nih.gov/ij). The quantified data for P-MLC were normalized to those of GAPDH.
doi:10.1371/journal.pone.0011272.g005
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Apoptosis analysis was analyzed using FITC-conjugated Annexin
V and PI as described previously [40]. The level of cellular ROS was
examined by FACS analysis using cells treated with 5 mMo fD C F
(Molecular Probes; Invitrogen) at 37uC as previously described [39].
Briefly, cells were incubated with DCF in DMEM medium for 30
minutes and then treated with PCBs (60 nM) with or without b-ME
(14.3 mM) for 6 hrs. Cells were then collected for analyses.
ROCK kinase activity assay
Breast cancer cells were treated with PCBs in medium with 1%
FBS for 24 hrs at 37uCa n d5 %C O 2. After two cold PBS washes,
1610
6 cells were lysed with M-PER Mammalian Protein Extraction
Reagent (Pierce). ROCK kinase activity was determined by the Rho-
kinase Assay kit (Cyclex Co, Japan) according to the manufacturer’s
protocol. The kinase activity in the vehicle control was defined as 1.
Transwell migration assay
After breast cancer cells were serum-starved for 24 hrs, cell
motility was assessed by the transwell (Corning) migration assay
following the standard protocol. Cells were plated on the upper
chamber (1610
4/insert) in 1% serum medium with or without
PCBs and allowed to migrate for 24 hrs with 10% serum medium
in the bottom as chemoattractant. Cells on the filter-side of the
upper chamber were cleaned with cotton swabs and the filters
were stained with 16DAPI solution after cold methanol fix. Cell
nuclei on the filters were visualized under a fluorescent
microscope.
Statistical analysis
Two-tailed Student’s t-test was used to analyze the statistical
significance of experimental data. All results are presented as
mean6SEM, and a P-value of ,0.05 determined statistical
significance.
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